| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ibio, Inc. (IBIO) has 9 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. IBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 479.0K | $785.6K | - | |
| CFO | 179.0K | $293.6K | - | |
| Other | 146.0K | $239.4K | - | |
| Dir | 13.5K | $22.1K | - | |
| Dir | 13.5K | $22.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | Sender Gary | Director | Buy | 9,191 | $2.72 | $24,999.52 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Brenner Martin87 | See Remarks | Buy | 9,191 | $2.72 | $24,999.52 | +100.7% | -52.5% | +5.9% | |
| Jan 10, 2025 | Arkowitz David61 | Director | Buy | 18,382 | $2.72 | $49,999.04 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Duran Felipe | Chief Financial Officer | Buy | 9,191 | $2.72 | $24,999.52 | +471.8% | -52.5% | +5.9% | |
| Jan 10, 2025 | Banjak Marc | Chief Legal Officer | Buy | 9,191 | $2.72 | $24,999.52 | +490.2% | -52.5% | +5.9% | |
| Jan 10, 2025 | Parada Antonio Bernardino Guimaraes | Director | Buy | 183,823 | $2.72 | $499,998.56 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Clark William D | Director | Buy | 1,838 | $2.72 | $4,999.36 | New | -52.5% | +5.9% | |
| Nov 1, 2023 | Brenner Martin87 | See Remarks | Sell | 4,881 | $0.27 | $1,295.91 | -2.6% | -78.4% | -51.4% | |
| Oct 3, 2023 | Brenner Martin87 | See Remarks | Sell | 5,267 | $0.30 | $1,591.69 | -2.7% | -77.2% | -63.1% | |
| Oct 2, 2023 | Brenner Martin87 | See Remarks | Sell | 4,215 | $0.31 | $1,310.87 | -2.1% | -77.6% | -62.3% |